Enanta Pharmaceuticals
ENTA
#7670
Rank
โ‚ฌ0.30 B
Marketcap
10,56ย โ‚ฌ
Share price
-2.64%
Change (1 day)
94.62%
Change (1 year)

Revenue for Enanta Pharmaceuticals (ENTA)

Revenue in 2025 (TTM): โ‚ฌ58.51 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ56.63 Million. In 2024 the company made a revenue of โ‚ฌ63.99 Million a decrease over the revenue in the year 2023 that were of โ‚ฌ66.59 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Enanta Pharmaceuticals from 2012 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ58.51 M-8.55%
2024 โ‚ฌ63.99 M-3.91%
2023 โ‚ฌ66.59 M-12.98%
2022 โ‚ฌ76.53 M-6.78%
2021 โ‚ฌ82.1 M-0.65%
2020 โ‚ฌ82.63 M-50.73%
2019 โ‚ฌ0.16 B-19.52%
2018 โ‚ฌ0.20 B91.59%
2017 โ‚ฌ0.10 B127.72%
2016 โ‚ฌ47.76 M-60.38%
2015 โ‚ฌ0.12 B17.92%
2014 โ‚ฌ0.10 B2675.61%
2013 โ‚ฌ3.68 M-92.92%
2012 โ‚ฌ52.03 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ81.65 B 144,093.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ49.13 B 86,658.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
โ‚ฌ53.02 B 93,525.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ10.40 B 18,271.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ56.35 B 99,420.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ41.78 B 73,678.40%๐Ÿ‡บ๐Ÿ‡ธ USA